alcian-blue and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

alcian-blue has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for alcian-blue and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia. Pathology, 2010, Volume: 42, Issue:1 Topics: Adult; Alcian Blue; Antineoplastic Agents; Benzamides; Bone Marrow; Bone Marrow Diseases; Coloring Agents; Humans; Hyaluronic Acid; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Remission Induction	2010

Article

Year

Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.

Pathology, 2010, Volume: 42, Issue:1

Topics: Adult; Alcian Blue; Antineoplastic Agents; Benzamides; Bone Marrow; Bone Marrow Diseases; Coloring Agents; Humans; Hyaluronic Acid; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Remission Induction

2010